SPRB Spruce Biosciences, Inc. - Seeking Alpha

A high-level overview of Spruce Biosciences, Inc. (SPRB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

CouponFollow Extension

75%
OFF

Spruce Biosciences, Inc. (SPRB) Latest Stock News - Seeking Alpha

6 days from now

Spruce Biosciences GAAP EPS of -$0.28 beats by $0.02, revenue of $2M beats by $0.84M SA News Mon, May 13 Spruce Biosciences stock craters 75% on failed Phase 2 study

seekingalpha.com

$1.00
OFF

Spruce Biosciences Faces Nasdaq Delisting Threat: Can A Reverse …

6 days from now

Nov 13, 2024 · Spruce Biosciences, Inc. faces a significant risk as it navigates the threat of delisting from Nasdaq due to the failure to maintain a minimum bid price of $1.00 for its …

businessinsider.com

$0.21
OFF

Spruce Biosciences (SPRB) Stock Price, News & Analysis - MarketBeat

6 days from now

4 days ago · Spruce Biosciences, Inc. (NASDAQ:SPRB) posted its earnings results on Monday, November, 11th. The company reported ($0.21) earnings per share (EPS) for the quarter, …

marketbeat.com

05%
OFF

Spruce Biosciences Inc, SPRB:NAQ Summary - FT.com

6 days from now

Oct 25, 2024 · On Friday, Spruce Biosciences Inc (SPRB:NAQ) closed at 0.5676, 38.05% above the 52 week low of 0.4112 set on Aug 12, 2024. 52-week range. ... Spruce Biosciences, Inc. is …

ft.com

$0.53
OFF

Spruce Biosciences Stock Price | SPRB Stock Quote, News, And …

6 days from now

On Friday 11/15/2024 the closing price of the Spruce Biosciences Inc Registered Shs share was $0.53 on BTT. Compared to the opening price on Friday 11/15/2024 on BTT of $0.51, this is a …

businessinsider.com

$47.92
OFF

Spruce Biosciences (SPRB) Earnings Date And Reports 2024

6 days from now

3 days ago · Spruce Biosciences (NASDAQ:SPRB) has a recorded net income of -$47.92 million. SPRB has generated -$0.94 earnings per share over the last four quarters. What is Spruce …

marketbeat.com

FAQs about SPRB Spruce Biosciences, Inc. - Seeking Alpha Coupon?

What is SPRB spruce Biosciences (SPRB) stock price?

Log in SPRB Spruce Biosciences, Inc. Stock Price & Overview Follow $0.550.017(+3.20%)4:00 PM 11/01/24 NASDAQ |$USD |Post-Market:$0.53-0.02(-2.85%)6:23 PM Summary Ratings Financials Earnings Dividends Valuation Growth Profitability Momentum Peers Options Charting All Analysis Comments News SEC Filings Press Releases Related Analysis SPRB Stock Price ...

Is spruce Biosciences (SPRB) a risk?

Spruce Biosciences, Inc. (SPRB) has disclosed a new risk, in the Share Price & Shareholder Rights category. Spruce Biosciences, Inc. faces a significant risk as it navigates the threat of delisting from Nasdaq due to the failure to maintain a minimum bid price of $1.00 for its common stock. ...

Who owns spruce Biosciences stock?

Spruce Biosciences' stock is owned by many different institutional and retail investors. Top institutional investors include Rosalind Advisors Inc. (3.67%) and Acadian Asset Management LLC (0.90%). Insiders that own company stock include Camilla V Simpson and Holdings A/S Novo. View institutional ownership trends. ...

Will spruce Biosciences delist from the NASDAQ?

Spruce Biosciences, Inc. faces a significant risk as it navigates the threat of delisting from Nasdaq due to the failure to maintain a minimum bid price of $1.00 for its common stock. Despite transferring its listing to the Nasdaq Capital Market, the company has until April 21, 2025, to meet compliance, potentially through a reverse stock split. ...

How did spruce Biosciences (SPRB) perform in a quarter?

Spruce Biosciences, Inc. (NASDAQ:SPRB) posted its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.18. The company had revenue of $2.89 million for the quarter, compared to analysts' expectations of $1.65 million. ...

Should you buy spruce Biosciences (SBP) stock?

The company's average rating score is 2.25, and is based on 2 buy ratings, 6 hold ratings, and no sell ratings. Spruce Biosciences has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Read more about Spruce Biosciences' stock forecast and price target. ...